Development and Implementation of a Professional Practices Evaluation during Radiopharmaceuticals Administration.
Nuclear Medicine
cancer patients management
drug administration
professional practices evaluation
quality of healthcare
radiopharmaceuticals
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
10 Nov 2022
10 Nov 2022
Historique:
received:
26
09
2022
revised:
04
11
2022
accepted:
07
11
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Securing both the patient and radiopharmaceuticals (RPs) circuit is an essential concern in nuclear medicine (NM). These circuits converge at the RP administration phase, a key step in patient management in NM. In a continuous quality improvement approach, we developed and implemented an evaluation of professional practices (EPPs) methodology focused on RPs injection to identify and correct deviations from good practices. The nuclear medicine technologists (NMTs) of a single center were evaluated. A specific audit grid was designed for this purpose, covering 4 main themes. Following the audit campaign, an improvement action plan was set up to address the non-conformities observed. Nine NMTs were audited on 4 RPs injections each. The mean total score was 93.36% with, on average, 7.01% and 3.00% of unmet and partially met criteria, respectively. In view of the non-compliance rates of hygiene and radiation protection items, theoretical reviews of these themes were included in the improvement action plan. As a part of the quality assurance system of a healthcare unit, EPPs are useful for identifying and correcting practice deviations at an early stage. They should be regularly repeated and combined with rigorous training and qualification of operators involved in RPs injection.
Identifiants
pubmed: 36360590
pii: healthcare10112247
doi: 10.3390/healthcare10112247
pmc: PMC9690994
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Nucl Med Technol. 2016 Dec;44(4):243-247
pubmed: 27634979
J Clin Pharm Ther. 2020 Oct;45(5):1114-1119
pubmed: 32519358
J Nucl Med Technol. 2012 Sep;40(3):183-6
pubmed: 22669938
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
Nat Rev Drug Discov. 2020 Sep;19(9):589-608
pubmed: 32728208
Hell J Nucl Med. 2020 Jan-Apr;23(1):60-66
pubmed: 32361717
Nucl Med Commun. 2020 Nov;41(11):1111-1116
pubmed: 32769813
Nucl Med Commun. 1995 Sep;16(9):721-3
pubmed: 7478403
Semin Nucl Med. 2022 Mar;52(2):94-113
pubmed: 34916044
EJNMMI Radiopharm Chem. 2021 Feb 12;6(1):8
pubmed: 33580358
J Clin Nurs. 2013 Feb;22(3-4):590-8
pubmed: 23228148
Semin Nucl Med. 2018 May;48(3):299-306
pubmed: 29626946
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3353-3364
pubmed: 35385986
Curr Probl Diagn Radiol. 2020 Sep - Oct;49(5):326-332
pubmed: 32222264
Br J Radiol. 2005 Oct;78(934):913-21
pubmed: 16177014
Eur J Hosp Pharm. 2021 May 7;:
pubmed: 33962998
BMJ Qual Saf. 2017 Jun;26(6):466-474
pubmed: 27707869
Intern Med J. 2015 Jun;45(6):609-17
pubmed: 25828553
Int J Qual Health Care. 2015 Oct;27(5):418-20
pubmed: 26294709
Adv Radiat Oncol. 2021 Oct 26;7(5):100827
pubmed: 36148380
Med J Aust. 2014 Jan 20;200(1):37-40
pubmed: 24438417
Semin Nucl Med. 2017 Nov;47(6):680-686
pubmed: 28969766
Nucl Med Commun. 2005 Nov;26(11):1037-41
pubmed: 16208183